{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:51:00Z","timestamp":1775065860833,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s00393-005-0638-3","type":"journal-article","created":{"date-parts":[[2005,6,19]],"date-time":"2005-06-19T15:39:04Z","timestamp":1119195544000},"page":"353-358","source":"Crossref","is-referenced-by-count":15,"title":["Fols\u00e4ure zur Reduktion der Methotrexat-Toxizit\u00e4t","Reducing toxicity of methotrexate with folic acid"],"prefix":"10.1007","volume":"64","author":[{"given":"P.","family":"Harten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"638_CR1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/art.1780390503","volume":"39","author":"American","year":"1996","unstructured":"American College of Rheumatology ad hoc comittee on clinical guidelines (1996) Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 39:723\u2013731","journal-title":"Arthritis Rheum"},{"key":"638_CR2","first-page":"830","volume":"24","author":"Andersen","year":"1997","unstructured":"Andersen LS, Hansen EL, Knudsen JB, Wester JU, Hansen GV, Hansen TM (1997) Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects. J Rheumatol 24:830\u2013837","journal-title":"J Rheumatol"},{"key":"638_CR3","first-page":"2110","volume":"27","author":"Bressole","year":"2000","unstructured":"Bressole F, Kinowski JM, Morel J, Pouly B, Sany J, Combe B (2000) Folic acid alters methotrexate availability in Patients with rheumatoid arthritis. J Rheumatol 27:2110\u20132114","journal-title":"J Rheumatol"},{"key":"638_CR4","unstructured":"British Society for Rheumatology (2000) National Guidelines for the Monitoring of Second Line Drugs,London"},{"key":"638_CR5","first-page":"783","volume":"18","author":"Buckley","year":"1991","unstructured":"Buckley LM (1991) Reply. J Rheumatol 18:783","journal-title":"J Rheumatol"},{"key":"638_CR6","first-page":"403","volume":"23","author":"Buckley","year":"1996","unstructured":"Buckley LM (1996) Reply. J Rheumatol 23:403\u2013404","journal-title":"J Rheumatol"},{"key":"638_CR7","first-page":"1158","volume":"17","author":"Buckley","year":"1990","unstructured":"Buckley LM, Vacek PM, Cooper SM (1990) Administration of folinic acid after low-dose methotrexate in patients with rheumatoid arthritis. J Rheumatol 17:1158\u20131161","journal-title":"J Rheumatol"},{"key":"638_CR8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","volume":"359","author":"Choi","year":"2002","unstructured":"Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173\u20131177","journal-title":"Lancet"},{"key":"638_CR9","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"Del Rincon","year":"2001","unstructured":"Del Rincon ID, Williams K, Stern MP, Freemann GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis rheuma 44:2737\u20132745","journal-title":"Arthritis rheuma"},{"key":"638_CR10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/39.10.1102","volume":"39","author":"Griffith","year":"2000","unstructured":"Griffith SM, Fisher J, Clarke S, Montgomery B, Jones PW, Saklatvala J, Dawes PT, Shadforth MF, Hothersall TE, Hassel AB, Hay EM (2000) Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term? Rheumatology (Oxford) 39:1102\u20131109","journal-title":"Rheumatology"},{"key":"638_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/ard.58.2.79","volume":"58","author":"Haagsma","year":"1999","unstructured":"Haagsma CJ, Blom HJ, van Riel PL, van\u2019t Hof MA, Giesenorf BA, van Oppenraaij-Emmerzaal D, van de Putte LB (1999) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79\u201384","journal-title":"Ann Rheum Dis"},{"key":"638_CR12","first-page":"1078","volume":"15","author":"Hanrahan","year":"1988","unstructured":"Hanrahan PS, Russell AS (1988) Concurrent use of folinic acid and methotrexate in rheumatoid arthritis. J Rheumatol 15:1078\u20131080","journal-title":"J Rheumatol"},{"key":"638_CR13","first-page":"2325","volume":"30","author":"Hoekstra","year":"2003","unstructured":"Hoekstra M, Van de Laar MA, Bernelot-Moens HJ, Kruijsen MW, Haagsma CJ (2003) Longterm survival study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis. J Rheumatol 30:2325\u20132329","journal-title":"J Rheumatol"},{"key":"638_CR14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.62.5.423","volume":"62","author":"Hoekstra","year":"2003","unstructured":"Hoekstra M, Van Ede AE, Haagsma CJ, Van de Laar MA, Huizinga TW, Kruijsen MW, Laan RF (2003) Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis. Ann Rheum Dis 62:423\u2013426","journal-title":"Ann Rheum Dis"},{"key":"638_CR15","first-page":"2230","volume":"24","author":"Hunt","year":"1997","unstructured":"Hunt PG, Rose CD, McIIvain-Simpson G, Tejani S (1997) The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. J Rheumatol 24:2230\u20132232","journal-title":"J Rheumatol"},{"key":"638_CR16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/rheumatology\/34.10.971","volume":"34","author":"Jobanputra","year":"1995","unstructured":"Jobanputra P, Hunter M, Clark D, Lambert CM, Hurst NP (1995) An audit of methotrexate and folic acid for rheumatoid arthritis. Experience from a teaching centre. Br J Rheumatol 34:971\u2013975","journal-title":"Br J Rheumatol"},{"key":"638_CR17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.50.12.913","volume":"50","author":"Joyce","year":"1991","unstructured":"Joyce DA, Will RK, Hoffmann DM, Laing B, Blackburn SJ (1991) Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Ann Rheum Dis 50:913\u2013914","journal-title":"Ann Rheum Dis"},{"key":"638_CR18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/keg175","volume":"42","author":"Kitas","year":"2003","unstructured":"Kitas GD, Erb N (2003) Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 42:607\u2013613","journal-title":"Rheumatology"},{"key":"638_CR19","unstructured":"Kommission Qualit\u00e4tssicherung der Deutschen Gesellschaft f\u00fcr Rheumatologie (2000) Methotrexat. In: \u201eQualit\u00e4tssicherung in der Rheumatologie\u201c. Verlag Steinkopff, Darmstadt, 5.3.7.1\u20135.3.7.3"},{"key":"638_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/1529-0131(200001)43:1<14::AID-ANR3>3.0.CO;2-7","volume":"43","author":"Krause","year":"2000","unstructured":"Krause D, Schleusser B, Herborn G, Rau R (2000) Response to methotrexate treatment is associated with reduced mortalitiy in patients with severe rheumatoid arthritis. Arthritis Rheum 43:14\u201321","journal-title":"Arthritis Rheum"},{"key":"638_CR21","first-page":"459","volume":"13","author":"Leeb","year":"1995","unstructured":"Leeb BF, Witzmann G, Ogris E, Studnicka-Benke A, Andel I, Schweitzer H, Smolen JS (1995) Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clin Exp Rheumatol 13:459\u2013463","journal-title":"Clin Exp Rheumatol"},{"key":"638_CR22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/art.1780301205","volume":"30","author":"Morgan","year":"1987","unstructured":"Morgan SL, Baggott JE, Altz-Smith M (1987) Folate status of rheumatoid arthritis patients receiving long-term, low-dose methotrexate therapy. Arthritis Rheum 30:1348\u20131356","journal-title":"Arthritis Rheum"},{"key":"638_CR23","first-page":"441","volume":"25","author":"Morgan","year":"1998","unstructured":"Morgan SL, Baggott JE, Lee JY, Alarcon GS (1998) Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol 25:441\u2013446","journal-title":"J Rheumatol"},{"key":"638_CR24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.7326\/0003-4819-121-11-199412010-00002","volume":"121","author":"Morgan","year":"1994","unstructured":"Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY, Koopmann WJ, Krumdieck CL, Alarcon GS (1994) Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind placebo-controlled trial. Ann Intern Med 121:833\u2013841","journal-title":"Ann Intern Med"},{"key":"638_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.1780330102","volume":"33","author":"Morgan","year":"1990","unstructured":"Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL, Alarcon GS (1990) The effect of folic acid supplementation on the toxicity of low dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 33:9\u201318","journal-title":"Arthritis Rheum"},{"key":"638_CR26","first-page":"CD000951","volume":"Rev","author":"Ortiz","year":"2000","unstructured":"Ortiz Z, Shea B, Suarez Almazor M, Moher D, Wells G, Tugwell P (2000) Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev (2):CD000951","journal-title":"Cochrane Database Syst"},{"key":"638_CR27","first-page":"625","volume":"17","author":"Ravelli","year":"1999","unstructured":"Ravelli A, Migliavacca D, Viola S, Ruperto N, Pistorio A, Martini A (1999) Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. Clin Exp Rheumatol 17:625\u2013627","journal-title":"Clin Exp Rheumatol"},{"key":"638_CR28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/030097499750042263","volume":"112","author":"Schiff","year":"1999","unstructured":"Schiff MH (1999) Leflunomide versus methotrexate: a comparison of the European and American experience. Scand J Rheumatol 112(Suppl):31\u201335","journal-title":"Scand J Rheumatol"},{"key":"638_CR29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/art.1780360609","volume":"36","author":"Shiroky","year":"1993","unstructured":"Shiroky JB, Neville C, Esdaile JM, Choquett D, Zummer M, Hazeltine M, Bykerk V, Kanji M, St. Pierre A, Robidoux L (1993) Low dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double blind, placebo controlled trial. Arthritis Rheum 36:795\u2013803","journal-title":"Arthritis Rheum"},{"key":"638_CR30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0049-0172(97)80018-2","volume":"27","author":"Stone","year":"1997","unstructured":"Stone J, Doube A, Dudson D, Wallace J (1997) Inadequate calcium, folic acid, vitamin E, zinc, and selenium intake in rheumatoid arthritis patients: results of a dietary survey. Semin Arthritis Rheum 27:180\u2013185","journal-title":"Semin Arthritis Rheum"},{"key":"638_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/03009749950155454","volume":"28","author":"Suzuki","year":"1999","unstructured":"Suzuki Y, Uehara R, Tajima C (1999) Elevation of serum hepatic aminotransferase during treatment of rheumatoid arthritis with low-dose methotrexate. Risk factors and response to folic acid. Scand J Rheumatol 28:273\u2013281","journal-title":"Scand J Rheumatol"},{"key":"638_CR32","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2165\/00002512-199609060-00008","volume":"9","author":"Tett","year":"1996","unstructured":"Tett SE, Triggs EJ (1996) Use of methotrexate in older patients. A risk-benefit assessment. Drugs Aging 9:458\u2013471","journal-title":"Drugs Aging"},{"key":"638_CR33","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/art.1780310712","volume":"31","author":"Tishler","year":"1988","unstructured":"Tishler M, Caspi D, Fishel B, Yaron M (1988) The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis Rheum 31:906\u2013908","journal-title":"Arthritis Rheum"},{"key":"638_CR34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","volume":"41","author":"Van Ede","year":"2002","unstructured":"Van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, Van de Putte LB (2002) Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology (Oxford) 41:658\u2013665","journal-title":"Rheumatology"},{"key":"638_CR35","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7","volume":"44","author":"Van Ede","year":"2001","unstructured":"Van Ede, AE, Laan RF, Rood MJ, Huizinga TWJ, van de Laar MA, van Denderen CJ, Westgeest TAA, Romme TC, De Rooij DJRAM, Jacobs MJM, De Boo TM, Van der Wilt GJ, Severens JL; Hartman M, Krabbe PFM, Dijkmans BAC, Breedveld FC, Van de Putte LB (2001) Effect of folic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis. Arthritis Rheum 44:1515\u20131524","journal-title":"Arthritis Rheum"},{"key":"638_CR36","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/anr.1780321214","volume":"32","author":"Weinblatt","year":"1989","unstructured":"Weinblatt ME, Fraser P (1989) Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy. Arthritis Rheum 32:1592\u20131596","journal-title":"Arthritis Rheum"},{"key":"638_CR37","first-page":"950","volume":"20","author":"Weinblatt","year":"1993","unstructured":"Weinblatt ME, Maier AL, Coblyn JS (1993) Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial. J Rheumatol 20:950\u2013952","journal-title":"J Rheumatol"},{"key":"638_CR38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/rheumatology\/keh088","volume":"43","author":"Whittle","year":"2004","unstructured":"Whittle SL, Hughes RA (2004) Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology 43:267\u2013271","journal-title":"Rheumatology"},{"key":"638_CR39","first-page":"36","volume":"30","author":"Wolfe","year":"2003","unstructured":"Wolfe F, Freundlich B, Strauss WL (2003) Increase in cardiovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30:36\u201340","journal-title":"J Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-005-0638-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-005-0638-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-005-0638-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:29:33Z","timestamp":1559060973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-005-0638-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["638"],"URL":"https:\/\/doi.org\/10.1007\/s00393-005-0638-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}